Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial

Wang, ZM; Zhuang, RY; Guo, X; Zhang, CL; You, Y; Chen, LS; Liu, WS; Zhang, Y; Luo, RK; Hou, YY; Lu, WQ; Zhou, YH

Zhou, YH (通讯作者)，Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.

CLINICAL CANCER RESEARCH, 2022; 28 (24): 5290

Abstract

Purpose: The treatment outcome for locally advanced or met-astatic soft-tissue sarcoma (STS) remains unsatisfactory. Anlotinib had demonstrated impres......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索